BGM Group Ltd. (ticker: BGM) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of BGM's SEC filings surfaces 5 active risk signals, including 4 late-filing signals, and 1 auditor-change signal. BGM reported $14.31M in revenue and -$861K for the period ending 2025-03-31, with operating cash flow of -$3.06M. Cash and equivalents stood at $9.65M (down 6.7% year-over-year). Total assets of $207.39M exceed total liabilities of $23.90M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
BGM Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for BGM Group Ltd. (BGM) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.